Primary Site >> Liver Cancer

Gene >> XPO1

Journal: Hepatology. 2005 Dec;42(6):1310-9.
Title: Role of HSP90, CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer.
Author: Pascale, Rosa M|Simile, Maria M|Calvisi, Diego F|Frau, Maddalena|Muroni, Maria R|Seddaiu, Maria A|Daino, Lucia|Muntoni, Maria D|De Miglio, Maria R|Thorgeirsson, Snorri S|Feo, Francesco
PMID: 16317707
Journal: Biochim Biophys Acta. 2006 Apr;1765(2):126-47.
Title: Hepatocellular carcinoma as a complex polygenic disease. Interpretive analysis of recent developments on genetic predisposition.
Author: Feo, F|De Miglio, M R|Simile, M M|Muroni, M R|Calvisi, D F|Frau, M|Pascale, R M
PMID: 16216419
Journal: Rev Recent Clin Trials. 2007 Sep;2(3):217-36.
Title: Dissection of signal transduction pathways as a tool for the development of targeted therapies of hepatocellular carcinoma.
Author: Calvisi, Diego F|Pascale, Rosa M|Feo, Francesco
PMID: 18474008
Journal: Curr Pharm Des. 2013;19(12):2318-25.
Title: Targeting the nuclear transport machinery by rational drug design.
Author: Mao, Lei|Yang, Yongliang
PMID: 23082981
Journal: Cancer Chemother Pharmacol. 2014 Sep;74(3):487-95.
Title: KPT-330 inhibitor of XPO1-mediated nuclear export has anti-proliferative activity in hepatocellular carcinoma.
Author: Zheng, Yun|Gery, Sigal|Sun, Haibo|Shacham, Sharon|Kauffman, Michael|Koeffler, H Phillip
PMID: 25030088
Journal: Tumour Biol. 2016 Mar;37(3):3405-15.
Title: HBx interacted with Smad4 to deprive activin a growth inhibition function in hepatocyte HL7702 on CRM1 manner.
Author: Shi, Ying|Zhang, Haipeng|Han, Zhu|Mi, Xuguang|Zhang, Wenyan|Lv, Mingyu
PMID: 26449823